Skip to main content

Table 2 Effect of labetalol infusion on cardiovascular parameters, reported as mean (± SD)

From: Retrospective evaluation of labetalol as antihypertensive agent in dogs

  T0 T1 T2 T3 T4
SAP 175 (±25)
p = 0.0019
152 (±38)
p = 0.0041
150 (±28)
p = 0.0079
144 (±28)
p = 0.0009
142 (±30)
p = 0.0002
MAP 130 (±22)
p = 0.0001
113 (±28)
p = 0.0519
108 (±20)
p = 0.0048
101 (±19)
p = 0.0004
98 (±20)
p < 0.0001
DAP 108 (±20)
p < 0.0001
90 (±25)
p = 0.0263
85 (±16)
p = 0.0017
80 (±14)
p < 0.0001
77 (±17)
p < 0.0001
HR 95 (±35)
p = 0.2454
88 (±20) 93 (±28) 95 (±22) 98 (±24)
  1. Thep value in the first column indicates the overall ANOVA p value, while the p values reported under the other columns indicate the post hoc p values in comparison with T0. SAP Systolic arterial pressure, MAP Mean arterial pressure, DAP Diastolic arterial pressure, HR Heart rate, T0 Beginning of the labetalol infusion; T1, T2, T3, T4: 15, 30, 45 and 60 min after the start of the infusion, respectively